Physician profile
Stephen J Jackson
NPI 1164411013
$1,342.24
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $541 · 2021: $176 · 2022: $357.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241.05 | 2020-2022 | |
| Allergan, INC. | $206.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $163.74 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.78 | 2019-2022 | |
| Lilly USA, LLC | $110.17 | 2020-2022 | |
| Novo Nordisk INC | $109.10 | 2019-2022 | |
| Amarin Pharma, INC. | $81.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $61.08 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $43.06 | 2019-2020 | |
| Corcept Therapeutics | $42.92 | 2020 | |
| Pfizer INC. | $36.82 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.55 | 2022 | |
| Amgen INC. | $23.50 | 2020 | |
| Glaxosmithkline, LLC. | $20.72 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.94 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14.51 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.38 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.